Global Endocrine Testing Market to Surpass US$ 4878.1 Million by 2027, Says Coherent Market Insights (CMI)

SEATTLE--()--According to Coherent Market Insights, the global endocrine testing market is estimated to be valued at US$ 3,403.0 million in 2020 and is expected to exhibit a CAGR of 5.3 % over the forecast period (2020-2027).

Key Trends and Analysis of the Global Endocrine Testing Market:

Increase in product approvals in the global endocrine testing market is expecting to drive the market growth of global endocrine testing market. For instance, in August 2020, DiaSorin, a biotechnological company, received CE marking for a novel Liaison Testosterone xt test used in diagnosis of fertility disorders in individuals such as hypogonadism in men and hypergonadism in men and women.

Increasing prevalence of testosterone disorders in individuals across the world is expected to drive the market growth of global endocrine testing. According to the report by National Center for Biotechnology Information in 2020, hypogonadism has affected approximately 40% of men above age 40 and 50% of men of age till 80.

Among region, North America endocrine testing market is expected to register higher growth rate, as companies are focused on strengthening their offerings in several areas of endocrine testing applications. For instance, LGC Maine Standards announced the launch of VALIDATE ACTHVerification Kit for fast and analytical measurement range (AMR) for identification of adrenocorticotropic hormone (ACTH).

Request Sample Copy of this Report @
https://www.coherentmarketinsights.com/insight/request-sample/1755

Key Market Takeaways:

The global endocrine testing market is expected to exhibit a CAGR of 5.3 % over the forecast period, owing to increasing trend of strategic collaborations, increasing product launches, and increasing mergers and acquisitions.

Competitive Landscape:

Key players operating in global endocrine testing market include Abbott Laboratories, Thermo Fisher Scientific, Bio-Rad Laboratories, Inc, Beckmann Coulter, Inc, Agilent Technologies, Inc, Siemens Healthineers AG, BioMérieux SA, Quest Diagnostics, and F. Hoffmann-La Roche AG.

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/1755

Market Segmentation:

  • Global Endocrine Testing Market, By Test :
    • Thyroid
    • Insulin
    • Follicle Stimulating Hormone
    • Luteinizing
    • Hormone
    • Estradiol
    • Testosterone
    • Progesterone
    • Human Chorionic Gonadotropin
    • Prolactin
    • Cortisol DHEA-S
    • Others
  • Global Endocrine Testing Market, By Diagnostic Technology :
    • Immunoassay
    • Tandem Mass Spectroscopy
    • Monoclonal and Polyclonal Antibodies
    • Sensors Technologies
    • Clinical Chemistry
    • Others
  • Global Endocrine Testing Market, By End User :
    •  Hospitals
    • Diagnostic Laboratories
    • Others
  • Global Endocrine Testing Market , By Region:
    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • Central Africa
      • North Africa

Related Market Intelligence Report:

COVID-19 Detection Kits Market, by Product Type (RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes), by Specimen Type (Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab, Sputum, and Others), by End User (Hospitals, Diagnostic Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Read more: https://www.coherentmarketinsights.com/market-insight/covid-19-detection-kits-market-3839

Cervical Cancer Diagnostic Tests Market, By Test Type (Pap Smear Test Procedure, Colposcopy Procedure, ECC Procedures), By Age Group (Age 20 - 40, Age above 40), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Read more: https://www.coherentmarketinsights.com/market-insight/cervical-cancer-diagnostic-tests-market-3994

Chromatography Market, By Product Type (Liquid (HPLC, UHPLC), Gas Liquid, Others (Ion Chromatography, LPLC, Flash, TLC and Chemical sensors)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Read more: https://www.coherentmarketinsights.com/market-insight/chromatography-market-4072

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide.

Contacts

Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights
Phone:
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com
Follow Us: LinkedIn | Twitter

Release Summary

The North-America endocrine testing market is expected to register a higher growth rate during forecast 2020-2027.

#Hashtags

Contacts

Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights
Phone:
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com
Follow Us: LinkedIn | Twitter